IntegriChain
IntegriChain is a prominent provider of a cloud-based channel management platform designed for life sciences and pharmaceutical manufacturers. It serves a diverse clientele, including nine of the top ten pharmaceutical companies, by facilitating effective channel collaboration and enhancing the efficiency of product distribution. The platform enables suppliers in pharmaceuticals, biopharmaceuticals, generics, and consumer health to manage their supply chain relationships, inventories, and orders across a wide network of retailers and distributors. By utilizing aggregated channel inventory and point-of-sale data, IntegriChain delivers informed applications and analytics that support customer operations, national accounts, and finance teams. This approach offers a more agile and mobile alternative to traditional enterprise resource planning systems. The company helps clients control distribution costs while ensuring product availability and revenue predictability, processing more than $200 billion in annual U.S. commerce and two billion transactions through its cloud platform each year.
Top Stages
5 past transactions
Blue Fin Group
Acquisition in 2022
Blue Fin Group is a management and consulting firm specializing in the pharmaceutical and biotech industries. Founded in 2001 and based in New York, the company provides comprehensive services that include research, strategy, and implementation to assist manufacturers in creating cohesive commercial strategies. These strategies encompass various aspects such as marketing, market access, field sales, pharmacy and distribution, and patient services, all aimed at optimizing patient outcomes. Blue Fin Group's experienced team has worked with over 300 manufacturers, ranging from those introducing their first asset to large global firms with diverse product portfolios, including cell and gene therapies, specialty medications, and generics. The firm is dedicated to ensuring that patients have affordable access to necessary medications through tailored product strategies, journey mapping, and commercial data analytics.
Cumberland Consulting Group
Acquisition in 2020
Cumberland Consulting Group is a prominent healthcare consulting firm, specializing in IT advisory, implementation, optimization, and outsourcing services. They cater to major payer, provider, and life sciences organizations, aiding them in maximizing operational efficiency through technology. As a vendor-neutral entity, Cumberland provides unbiased recommendations tailored to clients' best interests. Their Life Science Division focuses on contracts, pricing, and compliance for pharmaceutical manufacturers, offering advisory services, business process outsourcing, analytics solutions, and systems implementation.
daVIZta
Acquisition in 2019
daVIZta, Inc. is a provider of revenue analytics and management solutions tailored for life sciences companies. Founded in 2010 and headquartered in Somerset, New Jersey, with an additional office in Pune, India, the company specializes in delivering insights throughout the revenue lifecycle. Its d-Rive suite of products supports finance and contracting professionals by addressing contracting revenue flows, offering tools for pre-deal analysis, post-deal monitoring, and gross-to-net analysis. Additionally, the d-Rive VIZualizer enhances business intelligence efforts by visually communicating key metrics. daVIZta also offers consulting, managed services, and data management solutions to help clients navigate the complexities of the commercial continuum, including deal modeling, claims processing, and government pricing automation. As of March 2019, daVIZta operates as a subsidiary of IntegriChain Incorporated.
Medical Communication Technologies
Acquisition in 2018
Medical Communication Technologies, Inc. is a company based in Acworth, Georgia, that specializes in government pricing and contracting software and services. Founded in 2000, the company focuses on addressing the strategic challenges faced by pharmaceutical and biotechnology manufacturers during critical phases of product commercialization. Its offerings include strategic reimbursement planning, patient services, and initiatives related to commercial payers, pharmacy benefit managers, and government contracting. Additionally, Medical Communication Technologies provides services such as government pricing, rebate processing for both government and commercial sectors, and support for commercialization and distribution planning, including third-party logistics and specialty pharmacy selection. The company also engages in trade relations and manages patient coupon rebate processing, catering specifically to the needs of pharmaceutical, biotechnology, and medical device manufacturers. As of February 2018, it operates as a subsidiary of IntegriChain Incorporated.
PharmaMetrics
Acquisition in 2017
PharmaMetrics, Inc. is a provider of contract operations and market access analytics services specifically tailored for the pharmaceutical industry. Founded in 1998 and headquartered in Fort Washington, Pennsylvania, the company specializes in Medicaid processing, government pricing, deal analysis, contract review, formulary compliance, and pricing optimization. It also offers contract advisory services, data management, and analytics to assist pharmaceutical companies in navigating complex market dynamics. PharmaMetrics serves a diverse client base, including notable firms such as ThromboGenics, Actavis, and Bristol-Myers Squibb. As of 2017, PharmaMetrics operates as a subsidiary of IntegriChain Incorporated, enhancing its capacity to deliver comprehensive solutions that streamline contract operations and improve market access for its clients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.